The Bullous Pemphigoid 230 Vesiculobullous Disorders (Serum) test detects antibodies against the BP230 protein, which are associated with autoimmune blistering conditions such as bullous pemphigoid. Metropolis Healthcare performs this test using highly sensitive immunoassay technology to ensure precise and reliable antibody detection. Identifying BP230 antibodies helps confirm diagnosis, differentiate between blistering disorders, and monitor disease activity. This test is especially useful for patients with chronic blistering, severe itching, or unexplained dermatological lesions.
Price:
Rs. 4,500.00
Sample Type: 2426
Fasting Not Required
Notes: B0067
Frequently Asked Questions (FAQ's):
What does the Bullous Pemphigoid 230 test include at Metropolis Healthcare?
It detects antibodies against BP230 to support evaluation of autoimmune blistering disorders.
How does Metropolis Healthcare perform this antibody test?
Metropolis Healthcare uses advanced immunoassays to accurately measure BP230 antibodies in serum.
Who should take this test at Metropolis Healthcare?
Patients with blistering skin conditions, intense itching, or suspected bullous pemphigoid may require this test.
Do I need any preparation before giving my sample at Metropolis Healthcare?
No special preparation is required unless advised by your physician.
How soon can I get results from Metropolis Healthcare?
Results are usually available within the standard laboratory turnaround time.
Is the test reliable at Metropolis Healthcare?
Yes, Metropolis Healthcare ensures dependable results through strict quality protocols and validated testing.
How can this test help my doctor?
It assists in confirming diagnosis and guiding appropriate treatment for autoimmune skin disorders.
Do I need a prescription for this test at Metropolis Healthcare?
A prescription is recommended to ensure proper interpretation and clinical follow-up.